This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Cost Savings With Intramuscular Anticholinergics

John S. Markowitz, Stephen McLeod-Bryant, and Cherry Wyant Jackson

Published: April 1, 2001

Article Abstract

Letter to the Editor

Sir: With the advent of atypical antipsychotics, novel anticonvulsant agents, and selective serotonin reuptake inhibitors, the pharmacotherapy of psychiatric disorders has changed tremendously in the last decade. Although these newer medications are generally better tolerated, and, in some cases, lessen associated costs of more frequent hospitalizations, they have greatly impacted hospital pharmacy budgets. With few of these newer medications available generically, there is little opportunity to decrease medication costs except in interventions such as tablet splitting.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: